Showing results (401-410 of 470) with videos related to
Sort By:
Pageof 47
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2015
A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced CancerAmita Patnaik, Paul Haluska, Anthony W Tolcher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter studyMatthew P Goetz, Matthew R Callstrom, J William Charboneau, et al.Therapeutic Advances in Medical Oncology|July 15, 2021
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysisJun Yin, Shaheenah Dawood, Romain Cohen, et al.Breast Cancer Research : BCR|May 21, 2020
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancerSwaathi Jayaraman, Xiaonan Hou, Mary J Kuffel, et al.Molecular Cancer Therapeutics|May 23, 2024
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast CancerAnran Chen, Beom-Jun Kim, Aparna Mitra, et al.Oncotarget|March 4, 2021
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumorsNaoko Takebe, Geraldine O'Sullivan Coyne, Shivaani Kummar, et al.Breast Cancer Research : BCR|June 10, 2024
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancerRoberto A Leon-Ferre, Kaitlyn R Whitaker, Vera J Suman, et al.Journal of the National Cancer Institute|December 11, 2014
Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studiesMatthew P Goetz, James X Sun, Vera J Suman, et al.NPJ Breast Cancer|February 13, 2020
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patientsNadine Norton, Bahaaeldin Youssef, David W Hillman, et al.The Journal of Clinical Endocrinology and Metabolism|May 12, 2026
Establishment of harmonized international reference ranges for plasma estradiol concentrations in postmenopausal womenJinghan Cui, Susan E Hankinson, Alvin M Matsumoto, et al.Pageof 47